In Brief: Vagistat-1
This article was originally published in The Tan Sheet
Executive Summary
Vagistat-1: Bristol-Myers Squibb launches 30-second television campaign for the one-dose 6.5% tioconazole vaginal yeast infection treatment May 12 featuring the tagline; "One real victory for women." One scene features a row of seven blocks representing for seven-day treatments; three blocks, representing three-day treatments, then are placed atop the seven. Finally, the three blocks are topped by one, which morphs into a box of Vagistat-1. The campaign is being handled by BDDP, a division of Wells Rich Greene. The product began shipping shortly after its approval by FDA on Feb. 11 ("The Tan Sheet" Feb. 17, p. 1)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning